Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 3/20 | 0.31 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.31 |
| ▸ | GSK3A | P49840 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10299522 | 0.90 | SMN1; SMN2 (0.43) | SMN1; SMN2CYP11B2HTR1AADRA1BADRA1A | |
| SCHEMBL7709836 | 0.90 | SMN1; SMN2 (0.47) | SMN1; SMN2HTR1AADRA1BADRA1A | |
| SCHEMBL14820495 | 0.87 | SMN1; SMN2 (0.46) | SMN1; SMN2HTR1AADRA1BADRA1A | |
| SCHEMBL13339631 | 0.84 | TSHR (0.33) | SMN1; SMN2 | |
| SCHEMBL14806816 | 0.75 | SMN1; SMN2 (0.41) | SMN1; SMN2HTR1AADRA1BADRA1A | |
| SCHEMBL761687 | 0.74 | MEN1 (0.39) | CYP19A1BACE1HTR1A | |
| SCHEMBL14806790 | 0.74 | SMN1; SMN2 (0.40) | SMN1; SMN2HTR1AADRA1BADRA1A | |
| SCHEMBL16189944 | 0.74 | — | — | |
| SCHEMBL8295688 | 0.74 | CHRM2 (0.42) | CHRM2CHRM3HTR1AADRA1BADRA1A | |
| SCHEMBL12600702 | 0.72 | CHRM2 (0.48) | SMN1; SMN2CHRM2CHRM3HTR1AADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1730142-B1 | NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS | SCHERING CORP (US) | 2011-06-29 | — | — | EP | disclosed |